Advertising Disclaimer »

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

Article

Mental Health Disorders in Children With Congenital Heart Disease

Vincent J. Gonzalez, Rachel T. Kimbro, Katherine E. Cutitta, John C. Shabosky, Mohammad F. Bilal, Daniel J. Penny and Keila N. Lopez
Pediatrics February 2021, 147 (2) e20201693; DOI: https://doi.org/10.1542/peds.2020-1693
Download PDF

Abstract

BACKGROUND: Data on anxiety, depression, and attention-deficit/hyperactivity disorder (ADHD) are lacking for youth with congenital heart disease (CHD), particularly those with simple CHD. This study aims to characterize these disorders in youth with CHD compared to those without CHD.

METHODS: A comparative cross-sectional study was conducted by using the electronic medical records of a large tertiary care hospital between 2011 and 2016. Inclusion criteria were youth aged 4 to 17 years with >1 hospitalization or emergency department visits. Exclusion criteria were patients with arrhythmias or treatment with clonidine and/or benzodiazepines. The primary predictor variable was CHD type: simple, complex nonsingle ventricle, and complex single ventricle. The primary outcome variable was a diagnosis and/or medication for anxiety and/or depression or ADHD. Data were analyzed by using logistic regression (Stata v15; Stata Corp, College Station, TX).

RESULTS: We identified 118 785 patients, 1164 with CHD. Overall, 18.2% (n = 212) of patients with CHD had a diagnosis or medication for anxiety or depression, compared with 5.2% (n = 6088) of those without CHD. All youth with CHD had significantly higher odds of anxiety and/or depression or ADHD. Children aged 4 to 9 years with simple CHD had ∼5 times higher odds (odds ratio: 5.23; 95% confidence interval: 3.87–7.07) and those with complex single ventricle CHD had ∼7 times higher odds (odds ratio: 7.46; 95% confidence interval: 3.70–15.07) of diagnosis or treatment for anxiety and/or depression. Minority and uninsured youth were significantly less likely to be diagnosed or treated for anxiety and/or depression or ADHD, regardless of disease severity.

CONCLUSIONS: Youth with CHD of all severities have significantly higher odds of anxiety and/or depression and ADHD compared to those without CHD. Screening for these conditions should be considered in all patients with CHD.

  • Abbreviations:
    ACHD —
    adult congenital heart disease
    ADHD —
    attention-deficit/hyperactivity disorder
    CBT —
    cognitive behavioral therapy
    CHD —
    congenital heart disease
    CI —
    confidence interval
    ED —
    emergency department
    ICD-9 —
    International Classification of Diseases, Ninth Revision
    NDD —
    neurodevelopmental disabilities
    NSV —
    nonsingle ventricle
    SV —
    single ventricle

    • What’s Known on This Subject:

    Data have revealed adolescents with complex congenital heart disease have higher burdens of mental health disorders compared with the general population. Data on anxiety, depression, and attention-deficit/hyperactivity disorder are lacking for children and in youth with simple cardiac defects.

    What This Study Adds:

    Youth with congenital heart disease of all severities have significantly higher odds of anxiety/depression and attention-deficit/hyperactivity disorder compared with their peers. Screening should be considered for all congenital heart disease patients and possibly for children with other chronic illnesses.

    Congenital heart disease (CHD) is the most common birth defect, affecting ∼1% of all live births.1 The spectrum of CHD is wide, ranging from simple (not requiring immediate or possibly any surgical intervention) to severe or complex (typically defined as CHD requiring surgical intervention within the first month to year of life).2 Although overall mortality has improved, most notably in those with complex CHD, many surgical and medical procedures are palliative, and these patients often require multiple interventions throughout their lifetime.3 Increased CHD survival is now resulting in a continually growing population of adolescents and adults with CHD; this has drawn more attention to the noncardiac comorbidities, including overall mental health, of patients with CHD.4

    There are multiple psychological theories that can potentially explain some of the mental health disorders seen in patients with CHD, such as stressful life events and sociocultural impacts (eg, parenting style).5–7 Cognitive models, including learned helplessness and negative information processing, may also contribute to the mental health of children with CHD, who often spend significant amounts of time in the hospital and undergo cardiac procedures and surgeries.5,6 The presence of underlying genetic syndromes, parental mental health disorders, cardiopulmonary bypass, prematurity, and prolonged hospitalizations are factors that increase the risk of neurodevelopmental disabilities (NDDs) and likely contribute to anxiety, depression, and attention-deficit/hyperactivity disorder (ADHD) in adolescents and adults with complex CHD.8–13 With recent data, it is estimated that 50% to 75% of children with complex CHD are affected by NDDs and reduced quality of life.8,12,13 Given that the aforementioned models extend into childhood, it is notable that there is a paucity of literature examining the treatment of these disorders in young patients and in those with simple CHD. Thus, the purpose with this study was to determine the prevalence of anxiety, depression, and ADHD in children with CHD and compare them with youth without CHD. We hypothesized that the prevalence of these conditions would likely be higher in youth with CHD compared with patients without CHD and that children with complex CHD would have higher rates of anxiety, depression, and ADHD compared with those with simple CHD.

    Methods

    The research was approved by multi-institutional review boards. Inpatient and emergency department (ED) records from Texas Children’s Hospital were queried from 2011 to 2016 (medication data not available for outpatient encounters). Inclusion criteria were youth 4 to 17 years with at least 1 electronic medical record of being hospitalized or seen in the ED and at least 1 hospital medication file; a cutoff age of 4 years was used because diagnoses of anxiety, depression, and ADHD can reliably be made at this age.14 Individual patients were treated as one record, regardless of their number of encounters. Exclusion criteria included patients >18 years, those with any arrhythmia, and treatment with clonidine or benzodiazepines (often used for sedation).

    The primary outcome variable was diagnosis or treatment with a medication for anxiety and/or depression, ADHD, or both (International Classification of Diseases, Ninth Revision [ICD-9] codes/list of medications, Supplemental Table 6). Given that the same medications are used to treat both conditions, the diagnoses of anxiety and depression were collapsed (the absolute reason for medication use could not be determined with available data). The primary predictor variable was whether the child had a diagnosis of CHD, which was defined by using the physiologic adult congenital heart disease (ACHD) criteria3 of complexity as simple, complex nonsingle ventricle (NSV), and complex single ventricle (SV) (CHD diagnoses, Supplemental Table 7). Sociodemographics served as secondary predictor variables. Sex was characterized as a dichotomous variable, with female as the referent. Age was assessed as a continuous measure for the initial regression model. For subsequent models, patients were grouped by age into categories of preadolescent (4–9 years), early adolescent (10–13 years), and late adolescent (14–17 years). Race or ethnicity was a categorical measure representing the parent-reported race or ethnicity of the child, with non-Hispanic white as the referent. Insurance type was a categorical measure and indicated the type of insurance held by the child at the time of the visit.

    The statistical significance of each predictor variable was defined as a P value <.05 and an odds ratio >1 or <1. The first logistic regression model assessed all patients, with age as a continuous variable. Two subsequent models were performed stratified by age groups; because of the small number of early and late adolescent patients with complex SV CHD, this subanalysis could not be completed. Data were analyzed by equity of proportions and logistic regression using Stata v15 (Stata Corp, College Station, TX).

    Results

    Patient Characteristics

    We identified 118 785 unique patients, 1164 (∼1%) of whom had CHD. Patient demographics are shown in Table 1. The majority of patients with CHD had simple (47.7%) or complex NSV (46.9%) lesions. Compared with patients without CHD, those with CHD had more 4- to 9-year-olds (61.0% vs 53.6%), were more male-predominant (56.8% vs 52.0%), had a higher percentage of non-Hispanic white individuals (38.8% vs 25.4%), and were more likely to be privately insured (48.5% vs 38.6%). We adjusted for all of these factors in our statistical multivariate models.

    View this table:
    TABLE 1

    Patient Population

    Prevalence of Anxiety and/or Depression and ADHD

    Table 2 details patients with a diagnosis or medication for anxiety and/or depression or ADHD, both by age and presence or absence of CHD diagnosis. Overall, children with CHD had a significantly higher prevalence of anxiety and/or depression (18.2% vs 5.2%, P < .05) and ADHD (5.1% vs 2.1%, P < .05). This held true when children were stratified by age (Table 2).

    View this table:
    TABLE 2

    Prevalence of Anxiety, Depression, ADHD, by Age and CHD Status

    Logistic Regression Models

    In the first logistic regression model, all patients were analyzed with age as a continuous variable. The odds of having a diagnosis or medication for anxiety and/or depression or ADHD increased as children aged (Table 3). Compared with children without CHD, those with CHD had ∼4 to 5 times the odds of diagnosis or treatment of anxiety and/or depression and ∼1.6 to 2.7 times the odds of ADHD (Table 3). Non-Hispanic Black, Hispanic, and Asian American or other race children with CHD were 47%, 52%, and 33% less likely to be diagnosed or treated for anxiety and/or depression, respectively (Table 3). For ADHD, non-Hispanic Black, Hispanic, and Asian American or other race children with CHD were 45%, 78%, and 86% less likely to be diagnosed or treated for this condition, respectively (Table 3). These odds held true even when controlling for insurance type.

    View this table:
    TABLE 3

    Logistic Regressions, All Hospitalized and ED Patients <18 Years

    For the second and third models, age was a categorical variable for anxiety and/or depression (Table 4) and ADHD (Table 5). All patients, with simple or complex CHD, had higher odds of being diagnosed or treated for anxiety and/or depression (Table 4) and/or ADHD (Table 5), compared with their peers without CHD. These odds were most pronounced for anxiety and/or depression in the preadolescent group, and in particular, for those with SV CHD diagnoses. Those with public insurance generally had higher odds of being diagnosed or treated for ADHD, compared with those with private insurance or self-pay (Table 5).

    View this table:
    TABLE 4

    Logistic Regressions, Stratified by Age, Anxiety and/or Depression

    View this table:
    TABLE 5

    Logistic Regressions, Stratified by Age, ADHD

    Discussion

    The results of our study demonstrate that patients with CHD, regardless of age or disease severity, appear to have a significantly higher burden of anxiety and/or depression and ADHD when compared with peers without CHD. Our study adds significantly to the body of mental health and CHD literature, because there are no studies that include an assessment of anxiety and/or depression and ADHD in young children or those with simple CHD. Our findings are consistent with current data in adolescents with complex CHD, which reveal an increase in anxiety symptoms,15 as well as studies in the literature suggesting an increased prevalence of anxiety, depression, and ADHD in adolescents with CHD.15–18 These findings also correlate with the limited data in children with other chronic illnesses, such as asthma or sickle cell disease, which suggest an increase in mental health disorders compared with their peers.19,20

    Our study is unique in that there are few published studies in which researchers use diagnosis codes and medication data instead of self-report surveys to evaluate for anxiety, depression, and ADHD in the CHD population <18 years of age. Given that most anxiety and/or depression and ADHD diagnoses are made in the outpatient setting, we feel that our prevalence data are likely generalizable beyond the inpatient or ED setting. Although choosing the inpatient or ED setting may raise the question of a selection bias toward sicker patients, current outpatient data are congruent and reveal a similar trend in NDDs and mental health disorders.15,21–23

    Anxiety and Depression

    Existing literature does not currently examine anxiety or depression in patients with CHD aged <10 years. This study demonstrates that young children, regardless of CHD complexity, have a higher odds of diagnosis or treatment of anxiety and/or depression. Thus, limiting screening for anxiety and/or depression to adolescents with SV CHD or ACHD patients may result in the underdiagnosis in children and those with simple CHD.

    The reported national prevalence of anxiety and depression in the general population of 2- to 11-year-olds is roughly 3% and 7%, respectively.24 Our study reveals a significantly higher prevalence, with ∼16% of patients with CHD aged 4 to 9 years having a diagnosis or medication for anxiety and/or depression. The etiology behind this increased odds of anxiety and/or depression in young patients with simple CHD is likely multifactorial. As previously mentioned, prematurity and underlying genetic syndromes in these patients (eg, trisomy 21, Turner syndrome, Marfan syndrome, Noonan syndrome) are commonly associated with ADHD, oppositional disorders, and anxiety or depression,25–28 and may inherently increase their risk of mental health disorders; <1% of patients in our data set were coded for one of the aforementioned genetic diagnoses. Additionally, the impact of increased parental stress, coping, and anxiety has been well described in parents of children with CHD.29,30 There are multiple theoretical models (eg, double ABCX, Thompson stress and coping model),31–33 as well as a model unique to infants with CHD,34,35 in support of this hypothesis. Obesity is a common acquired condition that is prevalent in the population of CHD patients and is correlated with higher rates of ADHD, depression, and conduct disorder diagnoses.36,37 Furthermore, the significant burden of noncardiac comorbidities (eg, endocrine and metabolic, gastrointestinal, gynecologic disorders) in the ACHD population likely contributes to an increase in mental health disorders as well; these may also affect pediatric populations with CHD who are seeing similar comorbidities at younger ages in the current era.37–39 Finally, there are data to suggest that adolescents and adults with any type of CHD are at increased risk for psychological comorbidities, including posttraumatic stress disorder, which may also occur in younger children.23,38,40

    Adolescent data in patients with CHD have previously revealed that those with a greater number of heart operations, lower systemic saturation, and complex SV disease were at significantly increased risk for having psychiatric diagnoses and behavioral disorders15–17,41 and had higher rates of mental health disorders compared with their peers.15–17,21,42 Our data reveal that adolescents with any type of CHD have a higher prevalence of anxiety and/or depression than their peers without CHD (19%–23% vs 6%–9%), but that the odds were less pronounced between those with and without CHD as they aged. One possible explanation behind this smaller difference between the groups is the higher national prevalence of anxiety and/or depression in adolescent populations (6%–11%24 for 12–17-year-olds), compared with preadolescent patients, regardless of chronic disease condition. One novel study finding is that adolescents with simple CHD have >2 times higher odds of anxiety and/or depression compared with peers without CHD. This group may contribute to studies revealing high rates of anxiety and depression in ACHD patients, with up to 50% meeting criteria for a mood or anxiety disorder.9,43,44

    Our data reveal a lower odds of diagnosis or treatment of anxiety and/or depression for non-Hispanic Black, Hispanic, and Asian American or other race patients, as compared with their non-Hispanic white peers regardless of age, despite prevalence of these conditions being similar in the general population.45 Potential reasons for this include disparities in access to and quality of mental health services for anxiety and/or depression for minority children, as compared with non-Latino white peers.46 Other studies have shown that cultural differences or stigma surrounding anxiety and depression and access to insurance that covers mental health services exist among these racial and ethnic groups, resulting in a lower likelihood of seeking care.46,47

    Our data support the notion that the population of patients with CHD, regardless of disease severity, would likely benefit from mental health screening and evidence-based therapy earlier in childhood. Data regarding the treatment of children with CHD remain limited. Two efficacious interventions for youth with CHD have been described, one focusing on disease management strategies and the other on relaxation and stress management.48–50 Parent management training and cognitive behavioral therapy (CBT) may effectively treat anxiety and depressive symptoms.51–53 There are emerging data to support CBT with the addition of pharmacotherapy in adults, with promising preliminary results revealing a reduction in both anxiety and depressive symptoms.54,55 Thus, it may be beneficial to have dedicated mental health providers who specialize in pediatric chronic illnesses working with younger CHD patients to provide CBT and pharmacotherapy together. Finally, there are limited data to suggest a possible role for e-health interventions to improve access to therapy for mental health disorders.56

    ADHD

    The overall national prevalence of children with ADHD is roughly 9% in children aged 3 to 17 years.57 Our data reveal a prevalence of ADHD diagnosis and treatment in youth with CHD aged 4 to 17 years of 5.1%, whereas the non-CHD population had a lower prevalence of ADHD of 2.1%. A potential explanation for this lower overall prevalence in patients without CHD is the current data focus on patients in Houston, Texas, where there is a lower prevalence of ADHD medication prescription than the national average.58

    Previous studies have shown that 29% of children aged 7 to 15 years undergoing any open-heart surgery <1 year screened positive for symptoms of ADHD.59 Similarly, in early school-aged children (5–10 years) with complex CHD, data show ∼30% of children received high-risk scores by parents for symptoms of inattention and hyperactivity.60 Thus, parental scores may potentially overestimate true diagnoses of ADHD. Our results add to the existing body of literature18,22,59,60 by demonstrating that youth with simple and complex CHD had a significant increase in ADHD compared with healthy peers.

    Other studies have shown the odds of ADHD diagnosis in younger children in the general population for African Americans, Hispanics, and children of other races and ethnicities being 69% (95% confidence interval [CI]: 60%–76%), 50% (95% CI: 34%–62%), and 46% (95% CI: 26%–61%) lower, respectively, compared with non-Hispanic white individuals.61 This may be because of a provider or caregiver’s misperception that inattention or poor behavior is part of the child’s temperament, as opposed to sequelae of underlying ADHD. A misdiagnosis could result in increased discipline instead of mental health services; studies show that Black children experience disproportionally high rates of school discipline.62 Parent management training has been shown to be effective in historically underserved populations, including minorities and those of lower socioeconomic status.63,64

    Anxiety and Depression, ADHD, and the Impact of Insurance

    Our data reveal a decreased odds of diagnosis and/or treatment of anxiety and/or depression and ADHD across all age groups for those patients without insurance, which is not surprising given the cost of mental health treatment. Children covered by consumer-driven and high-deductible private insurance plans have significantly higher out-of-pocket expenditures for mental health services compared with other types of private insurance, which may end in families not being able to afford these services.65 Fortunately, Medicaid and Children’s Health Insurance Program services require that enrolled children receive a range of medically necessary services, including mental health services.66 This is of particular importance because untreated mental health disorders in children can lead to costly outcomes, such as school dropout, substance use, and suicide.67

    Limitations

    Although, in this study, we demonstrate multiple significant findings in the prevalence of anxiety and/or depression and ADHD in children with varied CHD severity, there are important limitations. Study data were collected at a single center by using diagnosis codes and medication records. Although this provides useful objective data, there are inherent difficulties that come with using ICD-9 diagnosis codes in that they bear the potential for inaccuracy. However, using a medication record helps provide increased accuracy by ensuring that the population was truly being treated for the diagnoses of anxiety and/or depression and ADHD, because these medications are solely used for these conditions. In our electronic medical record data, 98% of patients with anxiety and/or depression and 63% of patients with ADHD were identified using medication records, supporting our decision not to rely solely on ICD-9 codes.

    Another limitation is that given the significant overlap in medications used to treat anxiety and depression, patients being treated for each condition separately could not be differentiated. Additionally, patients being treated with benzodiazepines and clonidine were excluded, because these medications are frequently used for sedation purposes, resulting in a potential underestimate of the true number of patients being treated for anxiety. Finally, for our study we used ED and inpatient data, which raises the possibility of selection bias toward a sicker CHD cohort. It is not uncommon for any patient with CHD, even those with simple CHD, to be hospitalized or seen in the ED at least once over a 6-year period. One study in particular demonstrated that children with CHD accounted for ∼3.7% of all hospitalizations in the United States for youth aged 0 to 20 years; ∼17% of these CHD hospitalizations had complex CHD, accounting for only 30% of CHD hospitalizations in patients aged 1 to 10 years and 25% of CHD hospitalizations of patients 11 to 20 years.68 We deliberately chose our population cohort to include patients with both simple and complex CHD, which reduces the likelihood of choosing sicker (more severe) patients with CHD. Adding ED visits also assisted in catching patients who were not hospitalized and increased our catchment of “less sick” patients. Finally, we elected to use an ED and inpatient data set because of the ability to access medication data to ensure accuracy of diagnosis. Outpatient medical records are often limited to ICD-9 codes for single visit diagnosis and do not encompass all of a patient’s diagnoses or medications.

    Conclusions

    Our study demonstrates significantly increased odds of anxiety and/or depression and ADHD in all youth with CHD, regardless of disease severity. In particular, we provide novel insight into mental health disorders in children aged 4 to 9 years, as well as those with simple CHD. With these findings, we emphasize the importance of potential screening for anxiety, depression, and/or ADHD at a young age in patients with CHD, regardless of disease severity. Furthermore, these data underscore the importance of recognizing potential racial or ethnic bias in diagnosing mental health in children with CHD, as well as enabling insurance coverage for treating these disorders. In the future, researchers should examine if these findings are specific to patients with CHD versus other childhood chronic diseases and investigate earlier mental health interventions to reduce the burden of anxiety, depression, and ADHD in the population of individuals with CHD.

    Footnotes

      • Accepted November 16, 2020.
    • Address correspondence to Vincent J. Gonzalez, Department of Pediatrics, Section of Pediatric Cardiology, Texas Children’s Hospital, 6651 Main St, Legacy Tower, E1920, Houston, TX 77030. E-mail: vincent.gonzalez{at}bcm.edu

    • FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.

    • FUNDING: Supported by grant K23 HL127164 (principal investigator: Dr Lopez) from the National Institutes of Health/National Heart Lung and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funded by the National Institutes of Health (NIH).

    • POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

    References

    1. ↵
      1. Loffredo CA
      . Epidemiology of cardiovascular malformations: prevalence and risk factors. Am J Med Genet. 2000;97(4):319–325
      OpenUrlCrossRefPubMed
    2. ↵
      National Heart, Lung, and Blood Institute. Congenital heart defects. Available at: https://www.nhlbi.nih.gov/health-topics/congenital-heart-defects. Accessed October 4, 2020
    3. ↵
      1. Stout KK,
      2. Daniels CJ,
      3. Aboulhosn JA, et al
      . 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines[published correction appears in Circulation. 2019;139(14):e831–e832]. Circulation. 2019;139(14):e637–e697
      OpenUrl
    4. ↵
      1. Lui GK,
      2. Saidi A,
      3. Bhatt AB, et al.; American Heart Association Adult Congenital Heart Disease Committee of the Council on Clinical Cardiology and Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; and Council on Quality of Care and Outcomes Research
      . Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2017;136(20):e348–e392
      OpenUrlAbstract/FREE Full Text
    5. ↵
      1. Bernaras E,
      2. Jaureguizar J,
      3. Garaigordobil M
      . Child and adolescent depression: a review of theories, evaluation instruments, prevention programs, and treatments. Front Psychol. 2019;10:543
      OpenUrl
    6. ↵
      1. Beck A,
      2. Alford B
      . Depression: Causes and Treatment, 2nd ed. Philadelphia, PA: University of Pennsylvania Press; 2009
    7. ↵
      1. Williamson DE,
      2. Birmaher B,
      3. Anderson BP,
      4. al-Shabbout M,
      5. Ryan ND
      . Stressful life events in depressed adolescents: the role of dependent events during the depressive episode. J Am Acad Child Adolesc Psychiatry. 1995;34(5):591–598
      OpenUrlCrossRefPubMed
    8. ↵
      1. Verrall CE,
      2. Blue GM,
      3. Loughran-Fowlds A, et al
      . ‘Big issues’ in neurodevelopment for children and adults with congenital heart disease. Open Heart. 2019;6(2):e000998
      OpenUrlAbstract/FREE Full Text
    9. ↵
      1. Kovacs AH,
      2. Saidi AS,
      3. Kuhl EA, et al
      . Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int J Cardiol. 2009;137(2):158–164
      OpenUrlCrossRefPubMed
      1. Bellinger DC,
      2. Jonas RA,
      3. Rappaport LA, et al
      . Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. N Engl J Med. 1995;332(9):549–555
      OpenUrlCrossRefPubMed
      1. Marino BS,
      2. Lipkin PH,
      3. Newburger JW, et al.; American Heart Association Congenital Heart Defects Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council
      . Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012;126(9):1143–1172
      OpenUrlAbstract/FREE Full Text
    12. ↵
      1. Ryan KR,
      2. Jones MB,
      3. Allen KY, et al
      . Neurodevelopmental outcomes among children with congenital heart disease: at-risk populations and modifiable risk factors. World J Pediatr Congenit Heart Surg. 2019;10(6):750–758
      OpenUrl
    13. ↵
      1. Latal B,
      2. Helfricht S,
      3. Fischer JE,
      4. Bauersfeld U,
      5. Landolt MA
      . Psychological adjustment and quality of life in children and adolescents following open-heart surgery for congenital heart disease: a systematic review. BMC Pediatr. 2009;9:6
      OpenUrlCrossRefPubMed
    14. ↵
      1. American Psychiatric Association
      . Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA: American Psychiatric Association; 2013
    15. ↵
      1. DeMaso DR,
      2. Calderon J,
      3. Taylor GA, et al
      . Psychiatric disorders in adolescents with single ventricle congenital heart disease. Pediatrics. 2017;139(3):e20162241
      OpenUrlAbstract/FREE Full Text
      1. Utens EM,
      2. Verhulst FC,
      3. Duivenvoorden HJ,
      4. Meijboom FJ,
      5. Erdman RA,
      6. Hess J
      . Prediction of behavioural and emotional problems in children and adolescents with operated congenital heart disease. Eur Heart J. 1998;19(5):801–807
      OpenUrlCrossRefPubMed
    17. ↵
      1. So SCY,
      2. Li WHC,
      3. Ho KY
      . The impact of congenital heart disease on the psychological well-being and quality of life of Hong Kong Chinese adolescents: a cross-sectional study. J Clin Nurs. 2019;28(17–18):3158–3167
      OpenUrl
    18. ↵
      1. Hansen E,
      2. Poole TA,
      3. Nguyen V, et al
      . Prevalence of ADHD symptoms in patients with congenital heart disease. Pediatr Int. 2012;54(6):838–843
      OpenUrlCrossRefPubMed
    19. ↵
      1. Goodwin RD,
      2. Messineo K,
      3. Bregante A,
      4. Hoven CW,
      5. Kairam R
      . Prevalence of probable mental disorders among pediatric asthma patients in an inner-city clinic. J Asthma. 2005;42(8):643–647
      OpenUrlCrossRefPubMed
    20. ↵
      1. Benton TD,
      2. Ifeagwu JA,
      3. Smith-Whitley K
      . Anxiety and depression in children and adolescents with sickle cell disease. Curr Psychiatry Rep. 2007;9(2):114–121
      OpenUrlCrossRefPubMed
    21. ↵
      1. Holland JE,
      2. Cassidy AR,
      3. Stopp C, et al
      . Psychiatric disorders and function in adolescents with tetralogy of fallot. J Pediatr. 2017;187:165–173
      OpenUrl
    22. ↵
      1. Bellinger DC,
      2. Wypij D,
      3. Rivkin MJ, et al
      . Adolescents with d-transposition of the great arteries corrected with the arterial switch procedure: neuropsychological assessment and structural brain imaging. Circulation. 2011;124(12):1361–1369
      OpenUrlAbstract/FREE Full Text
    23. ↵
      1. Toren P,
      2. Horesh N
      . Psychiatric morbidity in adolescents operated in childhood for congenital cyanotic heart disease. J Paediatr Child Health. 2007;43(10):662–666
      OpenUrlCrossRefPubMed
    24. ↵
      1. Ghandour RM,
      2. Sherman LJ,
      3. Vladutiu CJ, et al
      . Prevalence and treatment of depression, anxiety, and conduct problems in US children. J Pediatr. 2019;206:256–267.e3
      OpenUrlCrossRefPubMed
    25. ↵
      1. Massin MM,
      2. Astadicko I,
      3. Dessy H
      . Noncardiac comorbidities of congenital heart disease in children. Acta Paediatr. 2007;96(5):753–755
      OpenUrlCrossRefPubMed
      1. Coe DA,
      2. Matson JL,
      3. Russell DW, et al
      . Behavior problems of children with Down syndrome and life events. J Autism Dev Disord. 1999;29(2):149–156
      OpenUrlCrossRefPubMed
      1. Russell HF,
      2. Wallis D,
      3. Mazzocco MMM, et al
      . Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects. J Pediatr Psychol. 2006;31(9):945–955
      OpenUrlCrossRefPubMed
    28. ↵
      1. Peters KF,
      2. Kong F,
      3. Horne R,
      4. Francomano CA,
      5. Biesecker BB
      . Living with Marfan syndrome I. Perceptions of the condition. Clin Genet. 2001;60(4):273–282
      OpenUrlCrossRefPubMed
    29. ↵
      1. Woolf-King SE,
      2. Anger A,
      3. Arnold EA,
      4. Weiss SJ,
      5. Teitel D
      . Mental health among parents of children with critical congenital heart defects: a systematic review. J Am Heart Assoc. 2017;6(2):e004862
      OpenUrlAbstract/FREE Full Text
    30. ↵
      1. Bishop MN,
      2. Gise JE,
      3. Donati MR,
      4. Shneider CE,
      5. Aylward BS,
      6. Cohen LL
      . Parenting stress, sleep, and psychological adjustment in parents of infants and toddlers with congenital heart disease. J Pediatr Psychol. 2019;44(8):980–987
      OpenUrl
    31. ↵
      1. McCubbin H,
      2. Patterson J
      . The family stress process: the double ABCX model of adjustment and adaptation. Marriage Fam Rev. 1983;6(1–2):7–37
      OpenUrlCrossRef
      1. Thompson R
      . Coping with the Stress of Chronic Childhood Illness. In: O’Quinn AN, ed. Management of Chronic Disorders of Childhood. Boston, MA: Hall; 1985:11–41
    33. ↵
      1. Mussatto K
      . Adaptation of the child and family to life with a chronic illness. Cardiol Young. 2006;16(suppl 3):110–116
      OpenUrlCrossRefPubMed
    34. ↵
      1. Lisanti AJ,
      2. Vittner D,
      3. Medoff-Cooper B,
      4. Fogel J,
      5. Wernovsky G,
      6. Butler S
      . Individualized family-centered developmental care: an essential model to address the unique needs of infants with congenital heart disease. J Cardiovasc Nurs. 2019;34(1):85–93
      OpenUrlCrossRef
    35. ↵
      1. Lisanti AJ
      . Parental stress and resilience in CHD: a new frontier for health disparities research. Cardiol Young. 2018;28(9):1142–1150
      OpenUrl
    36. ↵
      1. Pinto NM,
      2. Marino BS,
      3. Wernovsky G, et al
      . Obesity is a common comorbidity in children with congenital and acquired heart disease. Pediatrics. 2007;120(5). Available at: www.pediatrics.org/cgi/content/full/120/5/e1157
    37. ↵
      1. Halfon N,
      2. Larson K,
      3. Slusser W
      . Associations between obesity and comorbid mental health, developmental, and physical health conditions in a nationally representative sample of US children aged 10 to 17. Acad Pediatr. 2013;13(1):6–13
      OpenUrlCrossRefPubMed
    38. ↵
      1. Udholm S,
      2. Nyboe C,
      3. Dantoft TM,
      4. Jørgensen T,
      5. Rask CU,
      6. Hjortdal VE
      . Small atrial septal defects are associated with psychiatric diagnoses, emotional distress, and lower educational levels. Congenit Heart Dis. 2019;14(5):803–810
      OpenUrl
    39. ↵
      1. Steele JM,
      2. Preminger TJ,
      3. Erenberg FG, et al
      . Obesity trends in children, adolescents, and young adults with congenital heart disease. Congenit Heart Dis. 2019;14(4):517–524
      OpenUrl
    40. ↵
      1. Moreland P,
      2. Santacroce SJ
      . Illness uncertainty and posttraumatic stress in young adults with congenital heart disease. J Cardiovasc Nurs. 2018;33(4):356–362
      OpenUrl
    41. ↵
      1. Uzark K,
      2. Lincoln A,
      3. Lamberti JJ,
      4. Mainwaring RD,
      5. Spicer RL,
      6. Moore JW
      . Neurodevelopmental outcomes in children with Fontan repair of functional single ventricle. Pediatrics. 1998;101(4 pt 1):630–633
      OpenUrlAbstract/FREE Full Text
    42. ↵
      1. Cohen M,
      2. Mansoor D,
      3. Langut H,
      4. Lorber A
      . Quality of life, depressed mood, and self-esteem in adolescents with heart disease. Psychosom Med. 2007;69(4):313–318
      OpenUrlAbstract/FREE Full Text
    43. ↵
      1. Gleason LP,
      2. Deng LX,
      3. Khan AM, et al
      . Psychological distress in adults with congenital heart disease: focus beyond depression. Cardiol Young. 2019;29(2):185–189
      OpenUrlPubMed
    44. ↵
      1. Westhoff-Bleck M,
      2. Briest J,
      3. Fraccarollo D, et al
      . Mental disorders in adults with congenital heart disease: unmet needs and impact on quality of life. J Affect Disord. 2016;204:180–186
      OpenUrlPubMed
    45. ↵
      1. Breslau J,
      2. Kendler KS,
      3. Su M,
      4. Gaxiola-Aguilar S,
      5. Kessler RC
      . Lifetime risk and persistence of psychiatric disorders across ethnic groups in the United States. Psychol Med. 2005;35(3):317–327
      OpenUrlCrossRefPubMed
    46. ↵
      1. Alegria M,
      2. Vallas M,
      3. Pumariega AJ
      . Racial and ethnic disparities in pediatric mental health. Child Adolesc Psychiatr Clin N Am. 2010;19(4):759–774
      OpenUrlCrossRefPubMed
    47. ↵
      1. Yeh M,
      2. McCabe K,
      3. Hough RL,
      4. Dupuis D,
      5. Hazen A
      . Racial/ethnic differences in parental endorsement of barriers to mental health services for youth. Ment Health Serv Res. 2003;5(2):65–77
      OpenUrlCrossRefPubMed
    48. ↵
      1. Tesson S,
      2. Butow PN,
      3. Sholler GF,
      4. Sharpe L,
      5. Kovacs AH,
      6. Kasparian NA
      . Psychological interventions for people affected by childhood-onset heart disease: a systematic review. Health Psychol. 2019;38(2):151–161
      OpenUrl
      1. Lee S,
      2. Lee J,
      3. Choi JY
      . The effect of a resilience improvement program for adolescents with complex congenital heart disease. Eur J Cardiovasc Nurs. 2017;16(4):290–298
      OpenUrl
    50. ↵
      1. Freedenberg VA,
      2. Hinds PS,
      3. Friedmann E
      . Mindfulness-based stress reduction and group support decrease stress in adolescents with cardiac diagnoses: a randomized two-group study. Pediatr Cardiol. 2017;38(7):1415–1425
      OpenUrl
    51. ↵
      1. Eyberg SM,
      2. Nelson MM,
      3. Boggs SR
      . Evidence-based psychosocial treatments for children and adolescents with disruptive behavior. J Clin Child Adolesc Psychol. 2008;37(1):215–237
      OpenUrlCrossRefPubMed
      1. Chronis AM,
      2. Jones HA,
      3. Raggi VL
      . Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2006;26(4):486–502
      OpenUrlCrossRefPubMed
    53. ↵
      1. Chase RM,
      2. Eyberg SM
      . Clinical presentation and treatment outcome for children with comorbid externalizing and internalizing symptoms. J Anxiety Disord. 2008;22(2):273–282
      OpenUrlCrossRefPubMed
    54. ↵
      1. Kovacs AH,
      2. Grace SL,
      3. Kentner AC,
      4. Nolan RP,
      5. Silversides CK,
      6. Irvine MJ
      . Feasibility and outcomes in a pilot randomized controlled trial of a psychosocial intervention for adults with congenital heart disease. Can J Cardiol. 2018;34(6):766–773
      OpenUrlPubMed
    55. ↵
      1. Ferguson M,
      2. Kovacs AH
      . An integrated adult congenital heart disease psychology service. Congenit Heart Dis. 2016;11(5):444–451
      OpenUrlPubMed
    56. ↵
      1. Thabrew H,
      2. Stasiak K,
      3. Hetrick SE,
      4. Wong S,
      5. Huss JH,
      6. Merry SN
      . E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions. Cochrane Database Syst Rev. 2018;8(8):CD012489
      OpenUrl
    57. ↵
      1. Danielson ML,
      2. Bitsko RH,
      3. Ghandour RM,
      4. Holbrook JR,
      5. Kogan MD,
      6. Blumberg SJ
      . Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. Children and Adolescents, 2016. J Clin Child Adolesc Psychol. 2018;47(2):199–212
      OpenUrlPubMed
    58. ↵
      1. Visser SN,
      2. Danielson ML,
      3. Bitsko RH, et al
      . Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry. 2014;53(1):34–46.e2
      OpenUrlCrossRefPubMed
    59. ↵
      1. Yamada DC,
      2. Porter AA,
      3. Conway JL, et al
      . Early repair of congenital heart disease associated with increased rate of attention deficit hyperactivity disorder symptoms. Can J Cardiol. 2013;29(12):1623–1628
      OpenUrlCrossRefPubMed
    60. ↵
      1. Shillingford AJ,
      2. Glanzman MM,
      3. Ittenbach RF,
      4. Clancy RR,
      5. Gaynor JW,
      6. Wernovsky G
      . Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics. 2008;121(4). Available at: www.pediatrics.org/cgi/content/full/121/4/:e759
    61. ↵
      1. Morgan PL,
      2. Staff J,
      3. Hillemeier MM,
      4. Farkas G,
      5. Maczuga S
      . Racial and ethnic disparities in ADHD diagnosis from kindergarten to eighth grade. Pediatrics. 2013;132(1):85–93
      OpenUrlAbstract/FREE Full Text
    62. ↵
      US Department of Education, Office for Civil Rights. Civil rights data collection data snapshot: school discipline. Washington, DC: Office for Civil Rights; 2014
    63. ↵
      1. Gross D,
      2. Fogg L,
      3. Webster-Stratton C,
      4. Garvey C,
      5. Julion W,
      6. Grady J
      . Parent training of toddlers in day care in low-income urban communities. J Consult Clin Psychol. 2003;71(2):261–278
      OpenUrlCrossRefPubMed
    64. ↵
      1. McCabe K,
      2. Yeh M
      . Parent-child interaction therapy for Mexican Americans: a randomized clinical trial. J Clin Child Adolesc Psychol. 2009;38(5):753–759
      OpenUrlCrossRefPubMed
    65. ↵
      1. Walter AW,
      2. Yuan Y,
      3. Cabral HJ
      . Mental health services utilization and expenditures among children enrolled in employer-sponsored health plans. Pediatrics. 2017;139(suppl 2):S127–S135
      OpenUrlAbstract/FREE Full Text
    66. ↵
      1. Howell E
      . Access to Children’s Mental Health Services under Medicaid and SCHIP. 2004
    67. ↵
      1. Takkunen A,
      2. Zlevor A
      . Addressing children’s mental health. LegisBrief. 2018;26(39)
    68. ↵
      1. Simeone RM,
      2. Oster ME,
      3. Cassell CH,
      4. Armour BS,
      5. Gray DT,
      6. Honein MA
      . Pediatric inpatient hospital resource use for congenital heart defects. Birth Defects Res A Clin Mol Teratol. 2014;100(12):934–943
      OpenUrlCrossRefPubMed
    Back to top

    In this issue

    Pediatrics
    Vol. 147, Issue 2
    1 Feb 2021
    View this article with LENS
    Email Article
    Request Permissions
    Article Alerts
    Citation Tools
    Mental Health Disorders in Children With Congenital Heart Disease
    Vincent J. Gonzalez, Rachel T. Kimbro, Katherine E. Cutitta, John C. Shabosky, Mohammad F. Bilal, Daniel J. Penny, Keila N. Lopez
    Pediatrics Feb 2021, 147 (2) e20201693; DOI: 10.1542/peds.2020-1693
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Print
    Download PDF
    Insight Alerts

    Jump to section

    Subjects